首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1520578

2024-2032 年按藥物類別、製劑類型、配銷通路和地區分類的制酸劑市場報告

Antacids Market Report by Drug Class, Formulation Type, Distribution Channel, and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球制酸劑市場規模達69IMARC Group美元。該市場正在經歷成長，主要是因為零售藥局的擴張、對非處方藥的偏好以及胃食道逆流（GERD）患者數量的增加推動了市場的成長。

制酸劑市場分析：

主要市場促進因素：全球患有胃食道逆流的人數不斷增加，刺激了制酸劑的需求。這是推動市場成長的關鍵因素之一。

主要市場趨勢：西瓜薄荷、果味穀物和草莓奶昔等主要參與者推出的調味和咀嚼型抗酸藥對制酸劑市場收入產生了積極影響。

地理趨勢：由於醫療保健支出不斷增加、人口老化和醫療保健產業擴張，亞太地區成為制酸劑最大的區域市場。

關鍵參與者：制酸劑產業的一些主要市場參與者包括雅培實驗室、阿斯特捷利康公司、拜耳公司、勃林格殷格翰國際有限公司、雷迪博士實驗室有限公司、葛蘭素史克公司、強生公司、輝瑞公司、寶潔公司、Reckitt Benckiser Group PLC、Sanofi SA、Sun Pharmaceutical Industries Ltd、Takeda Pharmaceutical Company Limited 等。

挑戰與機會：制酸劑市場的挑戰在於胃酸逆流的替代治療方法的存在，而機會則在於新興市場和治療消化問題的創新配方。

制酸劑市場趨勢：

胃食道逆流症 (GERD) 的影響

根據美國國家醫學圖書館 2022 年的報告，2019 年有 7.8395 億人受到胃食道逆流的影響。制酸劑因其多種特性而被認為是治療胃酸過多的最佳方法。人們意識到制酸劑可以快速緩解疼痛，並且其易於獲取進一步促進了制酸劑市場的成長。

老年人口增加導致人口結構變化

老年人越來越了解制酸劑的重要性，因為它們具有快速緩解酸性物質的功效。因此，他們經常服用或購買制酸劑來控制這些消化問題。可以說，人口老化率上升的國家在全球的制酸劑銷售量可能會更高。世界衛生組織（WHO）2022年報告稱，到2030年和2050年，每6人中就有1人年齡在60歲或以上。。

由於易於獲取，人們對非處方藥 (OTC) 的依賴日益增加

在世界範圍內，非處方療法是治療輕微症狀的首選藥物，這刺激了制酸劑的需求。制酸劑可以透過藥房、雜貨店和線上平台輕鬆獲得，因此在自我藥療中發揮著至關重要的作用。制酸劑具有成本效益和節省時間的優點，非常適合當今的人們。 IMARC Group的研究報告提到，到2032年，全球非處方藥（OTC）市場將達到2,759億美元。

制酸劑市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據藥物類別、製劑類型和配銷通路對市場進行了分類。

按藥物類別細分：

質子幫浦抑制劑

H2拮抗劑

酸中和劑

促動力劑

質子幫浦抑制劑佔大部分市場佔有率

該報告根據藥物類別提供了詳細的市場細分和分析。這包括質子幫浦抑制劑、H2 拮抗劑、酸中和劑和促動力劑。根據該報告，質子幫浦抑制劑代表了最大的部分。

質子幫浦抑制劑是如此有效和可靠，以至於每個人都希望它們能夠減少胃酸和消化不良。醫療保健專業人員根據胃酸倒流的嚴重程度開出處方，導致其銷售量更高。主要參與者正在擴大他們的市場，因為他們知道人們正在了解質子幫浦抑制劑對體內的正面影響。例如，Daewon Pharmaceutical 於 2022 年在韓國推出了首款質子幫浦抑制劑藥物，名為 Escorten。

按配方類型細分：

藥片

液體

粉末

其他

平板電腦佔據產業最大佔有率

報告還根據配方類型對市場進行了詳細的細分和分析。這包括片劑、液體、粉末等。報告稱，平板電腦佔據了大部分市場佔有率。

平板電腦具有易於存放、運輸和管理等優點，使其深受個人歡迎。片劑很方便，因為它們可以隨時隨地用水輕鬆服用。無論是在辦公室、家裡或旅行中，人們都可以透過片劑藥物快速緩解胃酸過多或消化不良。與液體或粉末製劑類型相比，片劑的保存期限延長被視為另一個優點。制酸劑市場上存在的各種片劑配方，如咀嚼片、延遲釋放片和發泡錠，進一步建立了強大的消費者基礎。

按配銷通路分類：

醫院藥房

零售藥局

其他

零售藥局代表領先的細分市場

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括醫院藥房、零售藥房等。報告稱，零售藥局佔據市場主導地位。

首先，世界各地的城市、郊區和農村地區都擁有眾多的零售藥局。制酸劑作為非處方藥非常受歡迎，零售藥局是購買制酸劑的重要管道。其次，零售藥局提供的抗酸藥物種類繁多，可以根據患者的喜好和需求滿足不同患者的需求。第三，零售藥品市場的主要競爭對手將重點放在收購和擴張上，以擴大其影響力。 Medly Pharmacy 於 2021 年收購 Pharmaca 以提供 360 度藥房服務就是這樣的例子。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

亞太地區引領市場，佔據最大的制酸劑市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，亞太地區在市場上享有領先地位。

印度和中國等人口稠密的國家是該地區最大的制酸劑市場，因為這些國家正在經歷生活方式的轉變和西方飲食習慣，通常會導致胃酸倒流和消化不良。此外，該地區人口老化被視為制酸劑市場的近期機遇，因為他們對消化問題高度敏感。與此一致的是，亞太地區有許多競爭激烈的主要參與者，它們注重合作夥伴關係和收購來擴大市場。這是由印度製藥公司 Dr. Reddy's Laboratories 於 2024 年從 Amyris Inc. 收購 MenoLabs 時完成的，以滿足亞太地區人們不斷變化的需求。

本報告回答的關鍵問題

全球制酸劑市場有多大？
2024-2032年全球制酸劑市場的預期成長率是多少？
推動全球制酸劑市場的關鍵因素是什麼？
COVID-19 對全球制酸劑市場有何影響？
根據藥物類別，全球制酸劑市場的細分如何？
根據製劑類型，全球制酸劑市場的細分如何？
基於配銷通路的全球制酸劑市場的細分是怎樣的？
全球制酸劑市場的關鍵地區有哪些？
全球制酸劑市場的主要參與者/公司有哪些？

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Pfizer Inc.
- Procter & Gamble Company
- Reckitt Benckiser Group PLC
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited

簡介目錄圖表

Product Code: SR112024A5082

The global antacids market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The market is experiencing growth mainly because of the expansion of retail pharmacies, preference for OTC drugs, and rising number of patients experiencing gastroesophageal reflux disease (GERD) are impelling the growth of the market.

Antacids Market Analysis:

Major Market Drivers: People suffering from GERD is increasing around the world, which is catalyzing the demand for antacids. This represents one of the key factors propelling the market growth.

Key Market Trends: The launch of flavored and chewable antacids drugs by key players like watermelon mint, fruity cereals, and strawberry milkshake is positively impacting the antacids market revenue.

Geographical Trends: Asia Pacific is the largest regional market for antacids because of the rising healthcare expenditure, aging population, and healthcare sector expansion.

Key Players: Some of the major market players in the antacids industry include Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., among many others.

Challenges and Opportunities: Challenges in the antacids market are the presence of alternative treatment for acid reflux, while opportunities lie in emerging markets and innovative formulations to treat digestive issues.

Antacids Market Trends:

Gastroesophageal reflux disease's (GERD) impact

783.95 million people were impacted by GERD in 2019 claimed by the report of the National Library of Medicine 2022. The more people going through the suffering of GERD, the more it is driving the demand for antacids. The best treatment for acidity is thought to be antacids because of their several qualities. Individuals are aware about the quick relief provided by antacids and their easy accessibility is further contributing to the antacids market growth.

Changing demographics because of rising geriatric population

Elderly people are understanding the importance of antacids because of their quick relief qualities from acidity. They are, as a result, a regular consumer or buyer of antacids to manage these digestive issues. It may be said that nations with increased aging population rates can have higher sales of antacids worldwide. As claimed by the World Health Organization's (WHO) report of 2022, 1 individual out of 6 will be of 60 years in age or over by 2030 and by 2050. The global population of those aged 60 and over will also reach 2.1 billion, up from 1.4 billion in 2020.

Rising reliance on over the counter (OTC) medicines due to their ease of availability

Non-prescribed remedies are highly preferred in the world to cure mild symptoms, which is catalyzing the antacids demand. Antacids are easily available via pharmacies, grocery stores, and online platforms and as a result play a crucial role in self-medication purposes. The cost-effectiveness and time saving benefits provided by antacids are making them highly suitable for people nowadays. The IMARC Group's research report mentions that the global market for over the counter (OTC) drugs will reach US$ 275.9 Billion by 2032.

Antacids Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on drug class, formulation type, and distribution channel.

Breakup by Drug Class:

Proton Pump Inhibitors

H2 Antagonist

Acid Neutralizers

Pro-Motility Agents

Proton pump inhibitors accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes proton pump inhibitors, H2 antagonist, acid neutralizers, & pro-motility agents. According to the report, proton pump inhibitors represent the largest segment.

Proton pump inhibitors are so effective and reliable that everyone wants them to cut down on stomach acid and indigestion. Healthcare professionals prescribed them as per the severity of acid reflux, leading to their higher sales. Key players are expanding their market as they know people are gaining knowledge about the positive impact of proton pump inhibitors in the body. For instance, Daewon Pharmaceutical introduced its first proton pump inhibitor medicine in Korea in 2022, known as Escorten.

Breakup by Formulation Type:

Tablet

Liquid

Powder

Others

Tablet holds the largest share of the industry

A detailed breakup and analysis of the market based on the formulation type have also been provided in the report. This includes tablet, liquid, powder, and others. According to the report, tablet accounts for the majority of the market share.

Easy storage, transportation, and administration are some benefits provided by tablets make them highly preferable among individuals. Tablets are hassle-free, as they can be easily consumed with water anywhere or on the go. Whether at office, home, or travel, people can get quick relief from acidity or indigestion through tablet drugs. The extended shelf life of tablets is viewed as another benefit compared to liquid or powder formulation type. Various tablets formulations present in the antacids market like chewable, delayed release, and effervescent are further creating a strong consumer base.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Retail pharmacies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and others. According to the report, retail pharmacies dominate the market.

In the first place, cities, suburbs, and rural areas all have numerous retail pharmacies around the world. Antacids as OTC drugs are highly popular & retail pharmacies are a significant outlet to purchase antacids. Secondly, the inclusion of a wide variety of antacids drugs in retail pharmacies can cater to several patients according to their preferences and demands. Thirdly, the focus of leading competitors in the retail pharmacy market on acquisition & expansion to increase their reach. The acquisition of Pharmaca by Medly Pharmacy in 2021 to deliver 360-degrees pharmacy services is one such example.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest antacids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific enjoys the leading position in the market.

The densely populated countries like India and China are the largest markets for antacids in this region, as these countries are undergoing lifestyle shifts and Western food habits, which generally results in acid reflux and indigestion. Moreover, aging population in the region is viewed as an antacids market recent opportunities due to their high susceptibility to digestive issues. In line with this, lots of key players are present in the Asia Pacific region that are highly competitive and focus on partnerships and acquisition to expand their market. This was done by Dr. Reddy's Laboratories, a pharma company in India, when it acquired MenoLabs from Amyris Inc. in 2024 to cater to the evolving needs of people in the Asia Pacific region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major antacids companies have also been provided. Some of the major market players in the antacids industry include:

Abbott Laboratories

AstraZeneca plc

Bayer AG

Boehringer Ingelheim International GmbH

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Johnson & Johnson

Pfizer Inc.

Procter & Gamble Company

Reckitt Benckiser Group PLC

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Takeda Pharmaceutical Company Limited.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

The development of new formulations and product variants is done by key players through research and development (R&D) activities. They are introducing antacid drugs with flavors such as Fruity Cereal to meet the evolving demands of consumers. Top companies are taking advantage of elevated awareness about gastrointestinal health among people in developing countries. They are also eyeing on acquiring small businesses in the market while creating opportunities via antacids market recent developments. Using the digital health solutions is the main help method, enabling them to provide better health results. One such example was presented by AstraZeneca in November 2023, which it launched Evinova, a health-tech business, to offer advanced digital health solutions.

Antacids Market News:

In 2022: Zydus Lifesciences received approval from the USFDA to introduce Famotidine tablets, which is a histamine H2 receptor blocker and plays a vital role in reducing acid amount in the stomach.

Key Questions Answered in This Report

1. How big is the global antacids market?
2. What is the expected growth rate of the global antacids market during 2024-2032?
3. What are the key factors driving the global antacids market?
4. What has been the impact of COVID-19 on the global antacids market?
5. What is the breakup of the global antacids market based on the drug class?
6. What is the breakup of the global antacids market based on the formulation type?
7. What is the breakup of the global antacids market based on the distribution channel?
8. What are the key regions in the global antacids market?
9. Who are the key players/companies in the global antacids market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Antacids Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Proton Pump Inhibitors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 H2 Antagonist
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Acid Neutralizers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Pro-Motility Agents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Formulation Type

7.1 Tablet
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Liquid
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Powder
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bayer AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Boehringer Ingelheim International GmbH
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Dr. Reddy's Laboratories Ltd.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 GlaxoSmithKline plc
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Johnson & Johnson
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Procter & Gamble Company
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Reckitt Benckiser Group PLC
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Sanofi S.A.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Sun Pharmaceutical Industries Ltd.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis
- 14.3.13 Takeda Pharmaceutical Company Limited
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Antacids Market: Major Drivers and Challenges
Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2023
Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Antacids Market: Breakup by Region (in %), 2023
Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Antacids Industry: SWOT Analysis
Figure 80: Global: Antacids Industry: Value Chain Analysis
Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Antacids Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2024-2032
Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Antacids Market: Competitive Structure
Table 7: Global: Antacids Market: Key Players

02-2729-4219

+886-2-2729-4219